Moderna Covid vaccine approved in UK children's jabs for ages six to 11 The vaccine's rollout still depends on the verdict of the Joint Committee on Vaccination Immunisation. Daily Record · Apr 14, 2022
Moderna vaccine given go-ahead for use on six to 11-year-olds in UK A decision on whether it will be offered still has to be made Wales Online · Apr 14, 2022
UK approves Moderna Covid vaccine for six to 11-year-olds ‘Spikevax’ jab declared ‘safe and effective’ for this age group The Independent UK · Apr 14, 2022
Moderna Covid vaccine approved for use on six to 11-year-olds in the UK The vaccine will still need to be considered by the Joint Committee on Vaccination and Immunisation to determine if it will be rolled out Daily Mirror · Apr 14, 2022
Why Did Moderna Recall Thousands Of COVID-19 Vaccine Doses In Europe? Moderna Inc (NASDAQ:MRNA) recalled 764,900 doses of its COVID-19 vaccine made by its Spanish contract manufacturer Rovi after a foreign body contaminated a vial. No safety issues have been identified, Moderna said, about the lots distributed in Norway, Poland, Portugal, Spain, and Sweden in January. Japanese authorities last year suspended the use of… Benzinga · Apr 11, 2022
Moderna recalls thousands of COVID vaccine doses in Europe Moderna Inc said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi after a vial was found contaminated by a foreign body. Reuters · Apr 8, 2022
What Are Whales Doing With Moderna Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Apr 7, 2022
The high-stakes push to get COVID vaccines to young children The Omicron variant and and anti-vaccine backlash are complicating the effort. Axios · Apr 7, 2022
Sadiq Khan calls on leading vaccine manufacturers to share Covid jab blueprints with world Exclusive: Sadiq Khan, alongside mayors of New York and Johannesburg, urged companies ‘to do all you can’ to promote vaccine equity and ‘help stop the unnecessary loss of life’ The Independent UK · Apr 6, 2022
Moderna co-founder joins board of surgical robot startup A big name in the medical field is joining the board of Galen Robotics, a biotech startup in Baltimore. Tribune News Service · Apr 6, 2022
No Evidence to Support Widespread Use of Fourth COVID Shot, Say EU Agencies EU health agencies said on Wednesday there was no evidence to support the use of a fourth dose of COVID-19 vaccines developed by Pfizer and Moderna in the general population, but they recommend a second booster for people aged 80 and above. There is no clear evidence in the European… Asharq Al-Awsat · Apr 6, 2022
Future of COVID boosters comes down to crucial meeting of FDA Advisers An all-star panel of COVID-19 experts will convene this week to hash out how and when vaccines should be updated to address future variants as the virus continues to rapidly mutate. Tribune News Service · Apr 5, 2022
See Why COVAX, African Union Refuse To Buy More Moderna's COVID-19 Vaccine COVAX, the global project to share COVID-19 vaccines, and the African Union have declined options to buy additional doses of Moderna Inc (NASDAQ:MRNA) COVID-19 vaccine despite the low immunization rate as developing nations struggle to allocate supplies. The African Union and Covax decided not to obtain more of the vaccine as developing nations struggle… Benzinga · Apr 5, 2022
COVAX, African Union Decline to Buy More Doses of Moderna’s COVID Shots COVAX, the global project to share COVID-19 vaccines, and the African Union have declined options to buy additional doses of Moderna's shot, as developing nations struggle to allocate supplies. A spokesperson for Gavi, part of the COVAX alliance, confirmed the news. The discussions with Moderna are part of "regular decision-making… Asharq Al-Awsat · Apr 5, 2022
Manchester Evening News · Apr 5, 2022 One of world’s first Omicron Covid-19 variant vaccines to be trialled in Greater Manchester Volunteers are being asked to step forward to take part in the study
Benzinga · Apr 5, 2022 mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT The CEOs of Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) have sha
Benzinga · Apr 1, 2022 What Are Whales Doing With Moderna Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
The Conversation · Mar 30, 2022 COVID-19 vaccines for the youngest children may be inching closer to authorization – a pediatrician explains how they're being tested For some parents of young children, the wait for COVID-19 vaccines has been long and agonizing.
Tribune News Service · Mar 29, 2022 FDA clears way for millions to get additional COVID-19 boosters WASHINGTON — U.S. regulators cleared second booster doses of COVID-19 vaccine from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE for adults 50 and older, making millions more people eligible for the shots as concern grows about a potential new wave of infections.
Benzinga · Mar 29, 2022 Here's Why Moderna Shares Are Rising Moderna Inc (NASDAQ: MRNA) shares are trading higher by 4.67% at $181.16 after the company received FDA approval for Emergency Use Authorization for a second booster dose of its COVID-19 vaccine.
Benzinga · Mar 29, 2022 FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People The FDA has approved a second round of the Moderna Inc (NASDAQ:
Tribune News Service · Mar 29, 2022 FDA clears way for millions to get additional COVID-19 boosters U.S. regulators cleared second booster doses of COVID-19 vaccine from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE for adults 50 and older, making millions more people eligible for the shots as concern grows about a potential new wave of infections.
Chicago Sun-Times · Mar 29, 2022 FDA approves another COVID booster for 50 and up The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster.
The Independent UK · Mar 29, 2022 FDA approves another Pfizer, Moderna Covid booster for 50 and up US regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna Covid-19 vaccine
The Times of India · Mar 29, 2022 World moves from shortages to possible glut of Covid-19 vaccines NEW YORK: After racing to build capacity and meet once seemingly insatiable orders for Covid-19 shots, the global vaccine industry is facing waning demand as many late-to-market producers fight over a slowing market.